What is the risk of HIV, hepatitis B, and hepatitis C transmission from a fresh cut caused by sharing a razor, and what post‑exposure management is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Risk of Bloodborne Virus Transmission from Shared Razor Cut

The risk of HIV transmission from a shared razor cut is extremely low, while hepatitis B poses the highest risk (23-62% from infected blood), and hepatitis C carries intermediate risk (0-10%); immediate wound care with soap and water is essential, followed by risk-stratified post-exposure prophylaxis based on the source person's infection status.

Immediate Management

Wash the wound immediately with soap and water 1. This is the critical first step for any blood exposure. Do not squeeze or manipulate the wound excessively.

Transmission Risk by Pathogen

Hepatitis B Virus (HBV)

  • Highest risk: 23-62% transmission rate after percutaneous exposure to HBV-positive blood in unvaccinated individuals 2
  • HBV remains viable on environmental surfaces for 7 days or longer at room temperature 2
  • This makes shared razors particularly concerning for HBV transmission
  • Chronic infection leads to premature death in 15-25% of infected persons from cirrhosis or liver cancer 2

Hepatitis C Virus (HCV)

  • Intermediate risk: 0-3% transmission rate, maximum 10% when source is HCV RNA-positive 3
  • Research confirms HCV transmission through shared razors, with odds ratio of 1.99 for home razor sharing and 2.34 for barbershop razor sharing 4
  • Blood contamination on barber clippers documented in 42% of samples 5

Human Immunodeficiency Virus (HIV)

  • Lowest risk: Substantially lower than HBV or HCV for percutaneous exposures
  • While exact percentages for razor cuts aren't specified, the risk is considerably less than needlestick injuries

Post-Exposure Prophylaxis Algorithm

Step 1: Evaluate the Source Person

  • Test source for HBsAg (HBV), anti-HCV (HCV), and HIV antibody using rapid testing if possible 1
  • If source is unknown or unavailable, assess community prevalence and exposure circumstances 2

Step 2: Evaluate the Exposed Person

  • Determine HBV vaccination status and response (anti-HBs levels) 1
  • Obtain baseline testing for all three viruses

Step 3: Provide Pathogen-Specific Prophylaxis

For HBV Exposure:

  • Unvaccinated persons: Administer hepatitis B vaccine series PLUS hepatitis B immune globulin (HBIG) if source is HBsAg-positive 1
  • Must be given within 24 hours for maximum effectiveness 6
  • Previously vaccinated with known adequate response: No treatment needed
  • Previously vaccinated with unknown or inadequate response: May need HBIG and/or vaccine booster depending on source status

For HCV Exposure:

  • No post-exposure prophylaxis is recommended 1
  • Perform baseline anti-HCV and ALT testing 1
  • Follow-up testing at 4-6 months with anti-HCV and ALT 1
  • Consider HCV RNA testing at 4-6 weeks if earlier diagnosis desired 1
  • If acute HCV infection develops, early interferon therapy may prevent chronicity 6, 3

For HIV Exposure:

  • Assess exposure risk: A superficial razor cut from shared use represents lower risk than deep percutaneous injury
  • For unknown source in low-prevalence settings, HIV PEP may not be warranted 1
  • If PEP is indicated, must start within 72 hours (ideally within 2 hours) 1
  • Basic regimen: Zidovudine + Lamivudine for 28 days 1
  • Consider expanded 3-drug regimen for higher-risk exposures 7

Follow-Up Testing Schedule

HBV:

  • Test for anti-HBs 1-2 months after last vaccine dose (if vaccine given) 1

HCV:

  • Baseline: anti-HCV and ALT
  • 4-6 months: Repeat anti-HCV and ALT 1
  • Optional: HCV RNA at 4-6 weeks for earlier detection 1

HIV:

  • Baseline, 6 weeks, 3 months, and 6 months 1
  • Test immediately if acute retroviral syndrome symptoms develop 1

Critical Caveats

Time is critical: HBV prophylaxis effectiveness drops significantly after 24 hours 6, and HIV PEP should ideally start within 2 hours 1.

HBV vaccination status is paramount: The single most important factor determining HBV risk. Adequately vaccinated individuals with documented response have minimal risk.

Source testing drives decisions: Without knowing the source's infection status, you must make risk-based decisions considering local prevalence. In the U.S., HBV prevalence is approximately 0.4% 2.

Shared razors are documented transmission vehicles: Multiple studies confirm blood contamination (42% of barber clippers) 5 and epidemiologic links to HCV transmission 4, making this a legitimate exposure requiring evaluation.

Advise the exposed person to seek immediate medical evaluation for any acute illness during the 6-month follow-up period, as this may indicate acute viral infection 1.

References

5
Research

Blood and virus detection on barber clippers.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2018

Related Questions

What is the risk of transmission of HIV, hepatitis B, and hepatitis C from a needle‑stick injury occurring during central venous line (CVL) suture fixation?
Is hepatitis C typically transmitted through a needle‑stick injury?
What are the recommended baseline and follow-up tests after occupational blood exposure for HIV, hepatitis B, and hepatitis C, and what prophylaxis should be given?
What is the appropriate treatment plan, including medication dosages, for a patient with hepatitis C?
Can active hepatitis C virus infection cause cholestasis?
In an 87-year-old woman with left buttock pain, new-onset headache, one day of bed confinement due to hip pain, hypotension (90/50 mm Hg), poor appetite and decreased activities of daily living, what are the possible diagnoses and should she be admitted?
What are the distinctive pain patterns of trochanteric bursitis versus advanced hip osteoarthritis (bone‑on‑bone) during standing, movement, and sleep?
What are the chances of reversing fatty liver disease with lifestyle modification (weight loss of 7‑10 % on a calorie‑restricted Mediterranean‑style diet, limiting added sugars and saturated fat, and ≥150 minutes/week moderate exercise) at each histologic stage: simple steatosis, non‑alcoholic steatohepatitis with mild fibrosis (stage 1‑2), and advanced fibrosis (stage 3‑4)?
In a patient with Behçet’s disease on azathioprine who contracts COVID‑19, should antiviral therapy be initiated?
According to the 2025–2026 Endocrine Society primary aldosteronism guidelines, is a 24‑hour urine aldosterone measurement required as a confirmatory test after a positive aldosterone‑to‑renin ratio screen?
What is the appropriate management of metabolic and neurologic shutdown in a 51‑year‑old patient with adhesive arachnoiditis, tethered cord syndrome, and chronic osteomyelitis secondary to spinal cord infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.